IBDEI0UU ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14192,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,14192,1,4,0)
 ;;=4^E10.329
 ;;^UTILITY(U,$J,358.3,14192,2)
 ;;=^5002595
 ;;^UTILITY(U,$J,358.3,14193,0)
 ;;=E10.331^^82^774^5
 ;;^UTILITY(U,$J,358.3,14193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14193,1,3,0)
 ;;=3^DM Type 1 w/ Moderate Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,14193,1,4,0)
 ;;=4^E10.331
 ;;^UTILITY(U,$J,358.3,14193,2)
 ;;=^5002596
 ;;^UTILITY(U,$J,358.3,14194,0)
 ;;=E10.339^^82^774^6
 ;;^UTILITY(U,$J,358.3,14194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14194,1,3,0)
 ;;=3^DM Type 1 w/ Moderate Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,14194,1,4,0)
 ;;=4^E10.339
 ;;^UTILITY(U,$J,358.3,14194,2)
 ;;=^5002597
 ;;^UTILITY(U,$J,358.3,14195,0)
 ;;=E10.341^^82^774^9
 ;;^UTILITY(U,$J,358.3,14195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14195,1,3,0)
 ;;=3^DM Type 1 w/ Severe Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,14195,1,4,0)
 ;;=4^E10.341
 ;;^UTILITY(U,$J,358.3,14195,2)
 ;;=^5002598
 ;;^UTILITY(U,$J,358.3,14196,0)
 ;;=E10.349^^82^774^10
 ;;^UTILITY(U,$J,358.3,14196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14196,1,3,0)
 ;;=3^DM Type 1 w/ Severe Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,14196,1,4,0)
 ;;=4^E10.349
 ;;^UTILITY(U,$J,358.3,14196,2)
 ;;=^5002599
 ;;^UTILITY(U,$J,358.3,14197,0)
 ;;=E10.351^^82^774^7
 ;;^UTILITY(U,$J,358.3,14197,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14197,1,3,0)
 ;;=3^DM Type 1 w/ Prolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,14197,1,4,0)
 ;;=4^E10.351
 ;;^UTILITY(U,$J,358.3,14197,2)
 ;;=^5002600
 ;;^UTILITY(U,$J,358.3,14198,0)
 ;;=E10.359^^82^774^8
 ;;^UTILITY(U,$J,358.3,14198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14198,1,3,0)
 ;;=3^DM Type 1 w/ Prolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,14198,1,4,0)
 ;;=4^E10.359
 ;;^UTILITY(U,$J,358.3,14198,2)
 ;;=^5002601
 ;;^UTILITY(U,$J,358.3,14199,0)
 ;;=E08.311^^82^774^33
 ;;^UTILITY(U,$J,358.3,14199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14199,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,14199,1,4,0)
 ;;=4^E08.311
 ;;^UTILITY(U,$J,358.3,14199,2)
 ;;=^5002510
 ;;^UTILITY(U,$J,358.3,14200,0)
 ;;=E08.319^^82^774^34
 ;;^UTILITY(U,$J,358.3,14200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14200,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,14200,1,4,0)
 ;;=4^E08.319
 ;;^UTILITY(U,$J,358.3,14200,2)
 ;;=^5002511
 ;;^UTILITY(U,$J,358.3,14201,0)
 ;;=E08.321^^82^774^35
 ;;^UTILITY(U,$J,358.3,14201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14201,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Mild Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,14201,1,4,0)
 ;;=4^E08.321
 ;;^UTILITY(U,$J,358.3,14201,2)
 ;;=^5002512
 ;;^UTILITY(U,$J,358.3,14202,0)
 ;;=E08.329^^82^774^36
 ;;^UTILITY(U,$J,358.3,14202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14202,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Mild Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,14202,1,4,0)
 ;;=4^E08.329
 ;;^UTILITY(U,$J,358.3,14202,2)
 ;;=^5002513
 ;;^UTILITY(U,$J,358.3,14203,0)
 ;;=E08.331^^82^774^37
 ;;^UTILITY(U,$J,358.3,14203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14203,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Moderate Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,14203,1,4,0)
 ;;=4^E08.331
